Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CoreWeave, Inc. (Nasdaq: CRWV) SEC filings page provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. As a publicly traded Software - Infrastructure company focused on AI cloud services, CoreWeave uses its filings to describe material agreements, financing arrangements, and significant corporate events.
In its Form 8-K filings, CoreWeave has reported material definitive agreements such as master services agreements and order forms with OpenAI, Meta Platforms, Inc., and NVIDIA Corporation, which govern access to cloud computing capacity and reserved capacity arrangements. The company has also disclosed credit agreements and delayed draw term loan facilities used to finance capital expenditures for GPU servers, infrastructure, and systems that support strategic customer contracts.
CoreWeave’s filings include detailed descriptions of its debt and capital structure, such as senior notes, revolving credit facilities, and convertible senior notes due 2031. These documents outline terms like interest rates, maturity dates, conversion features, capped call transactions, guarantees by subsidiaries, and financial covenants. Investors can review these filings to understand how CoreWeave funds its AI infrastructure and manages potential dilution.
Other 8-K filings cover topics such as the termination of a proposed merger agreement, changes in classification of equity related to preferred stock put rights, and the registration of Class A common stock on The Nasdaq Stock Market LLC under the symbol CRWV. Results of operations and financial condition for specific quarters are also furnished via 8-K exhibits.
On Stock Titan, AI-powered tools can help summarize lengthy CoreWeave filings, highlight key terms in documents like credit agreements and indentures, and surface information on topics such as material customer contracts, new financing facilities, and significant corporate events. Users can quickly locate references to items like convertible notes, capped call transactions, or major AI infrastructure commitments without reading every page.
CoreWeave, Inc. executive Goldberg Chen reported an insider transaction involving restricted stock units and company shares. On February 5, 2026, 37,500 restricted stock units were converted into Class A Common Stock at no cost. The same day, 17,985 shares of Class A Common Stock were sold at a weighted average price of $79.6937 per share to satisfy tax withholding obligations arising from the RSU vesting.
After these transactions, Chen directly held 42,859 shares of Class A Common Stock and 375,000 restricted stock units, each representing a right to receive one share upon settlement. The RSU award vested as to one-quarter of the total on August 5, 2025 and continues to vest in equal installments on specified future dates, subject to continued service.
CoreWeave, Inc. insider Chen Goldberg has filed a notice of proposed stock sales under Rule 144. The filing covers an intended sale of 17,985 shares of Class A common stock through Morgan Stanley Smith Barney on or about 02/05/2026 on the NASDAQ. The shares were acquired from the issuer on the same date as compensation in the form of restricted stock units.
The notice also lists prior sales over the past three months by the same insider: 13,740 shares of Class A common stock sold on 11/11/2025 for gross proceeds of 1,451,081.4, and 19,180 shares sold on 11/05/2025 for gross proceeds of 2,268,994. The filing states that 386,401,201 shares of Class A common stock were outstanding. By signing, the seller represents they are not aware of undisclosed material adverse information about CoreWeave.
CoreWeave, Inc. insider Chen Goldberg has filed a notice of proposed stock sales under Rule 144. The filing covers an intended sale of 17,985 shares of Class A common stock through Morgan Stanley Smith Barney on or about 02/05/2026 on the NASDAQ. The shares were acquired from the issuer on the same date as compensation in the form of restricted stock units.
The notice also lists prior sales over the past three months by the same insider: 13,740 shares of Class A common stock sold on 11/11/2025 for gross proceeds of 1,451,081.4, and 19,180 shares sold on 11/05/2025 for gross proceeds of 2,268,994. The filing states that 386,401,201 shares of Class A common stock were outstanding. By signing, the seller represents they are not aware of undisclosed material adverse information about CoreWeave.
FMR LLC reports beneficial ownership of 7,922,651.24 shares of CoreWeave Inc. Class A common stock, representing 2.1% of the class. The filing, an amended Schedule 13G as of December 31, 2025, reflects holdings reported by both FMR LLC and Abigail P. Johnson.
The shares are held with sole dispositive power and no shared voting or dispositive power. The securities are stated to be acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of CoreWeave.
FMR LLC reports beneficial ownership of 7,922,651.24 shares of CoreWeave Inc. Class A common stock, representing 2.1% of the class. The filing, an amended Schedule 13G as of December 31, 2025, reflects holdings reported by both FMR LLC and Abigail P. Johnson.
The shares are held with sole dispositive power and no shared voting or dispositive power. The securities are stated to be acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of CoreWeave.
CoreWeave, Inc. Chief Development Officer McBee Brannin reported insider transactions for entities associated with him on February 2, 2026. Canis Major 2025 Family Trust LLC, Canis Minor 2025 Family Trust LLC and related 2025 GRATs converted Class B Common Stock into Class A Common Stock, with each Class B share convertible one-for-one.
After these conversions, the trusts and GRATs sold multiple blocks of Class A Common Stock at weighted average prices disclosed between $88.60 and $94.66 per share, under a Rule 10b5‑1 trading plan adopted on November 17, 2025. Following the reported trades, each entity continues to hold Class A shares as shown in the filing’s post-transaction balances.
CoreWeave, Inc. Chief Development Officer Brannin McBee reported multiple share conversions and sales dated 02/02/2026. He converted 102,830 shares of Class B Common Stock into Class A, then sold several Class A blocks at weighted average prices ranging from about $89.03 to $94.65 per share, leaving 248,664 Class A shares held directly.
Related entities also moved shares. The Brannin J. McBee 2022 Irrevocable Trust, Canis Major 2024 Irrevocable Trust LLC and the Canis Major SM Trust converted and sold Class A shares, and remaining indirect holdings include trusts plus Class B shares held by McBee’s spouse. The sales were made under a Rule 10b5-1 trading plan adopted on November 17, 2025.
CRWV has a planned sale notice under Rule 144 for 281,250 shares of common stock, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on or around 02/04/2026. The filing lists an aggregate market value of 25329375.00 for these shares and notes that 386401201 common shares were outstanding, with the securities listed on NASDAQ.
The 281,250 shares to be sold were acquired as Founders Shares from the issuer on 12/27/2023, in the same amount, with payment dated 12/27/2023 and nature of payment marked as N/A. The notice also details multiple recent sales of the issuer’s common stock over the past three months by entities and persons such as WEST CLAY CAPITAL LLC, BRIAN VENTURO, YOLO APV TRUST, YOLO ECV TRUST, and a Non-Affiliate Donee, including individual transactions of up to 281250 shares and gross proceeds as high as 25810087.50, some executed under 10b5-1 trading plans.
CareView Communications (symbol CRWV) filed a notice of proposed insider share sales. The filing covers 8,335 common shares with an aggregate market value of $776,738.65, to be sold through Morgan Stanley Smith Barney on the Nasdaq market. The issuer reports 386,401,201 common shares outstanding. The 8,335 shares were originally acquired on 02/25/2019 as founder shares from the issuer.
The document also lists extensive Rule 10b5-1 programmed sales in the past three months by Brannin McBee, related trusts and GRATs, and a non-affiliate donee. Individual transactions include a non-affiliate donee sale of 257,733 common shares for $19,592,527.61, alongside multiple other large 10b5-1 sales of CRWV common stock.
CRWV reports a planned Rule 144 sale of 25,000 common shares, with an aggregate market value of $2,329,750.00. These shares are founder shares acquired on February 25, 2019 directly from the issuer, with full payment made that same day.
The notice states that 386,401,201 common shares were outstanding, and the proposed sale is to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange around February 2, 2026. The filing also lists extensive recent sales under Rule 10b5-1 trading plans by Brannin McBee-related trusts and entities, including a non-affiliate donee sale of 257,733 shares for $19,592,527.61 during the prior three months.
This Form 144 notice discloses a planned sale of 1,000 shares of common stock of CRWV through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with an approximate sale date of 02/02/2026. The shares to be sold were acquired as founders shares from the issuer on 02/25/2019.
The filing also lists extensive Rule 10b5-1 sales of CRWV common stock during the past three months by Brannin J. McBee, related trusts and GRATs, and a non-affiliate donee. Examples include 102835 common shares sold on 01/26/2026 for $10432309.16, and 257733 shares sold on 12/01/2025 for $19592527.61. The person on whose behalf the shares are sold represents that they do not know any undisclosed material adverse information about the issuer’s current or prospective operations.
A shareholder filed a Form 144 notice to sell 1,000 shares of common stock through Morgan Stanley Smith Barney LLC, targeting an approximate sale date of 02/02/2026 on NASDAQ with an aggregate market value of $93,190.
The notice states that these 1,000 shares were acquired on 02/25/2019 as founder shares from the issuer, and indicates 386,401,201 shares of this class outstanding. This is a planned resale by an existing holder, not a new share issuance.
The filing also lists extensive Rule 10b5‑1 plan transactions over the past three months by Brannin McBee, multiple Canis Major and Canis Minor trusts and related entities, detailing repeated blocks of common-share sales and their gross proceeds.